|
TOM1L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.50932649395963E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.49610348951524E-11 |
| Normal-vs-Stage2 |
2.03199999999626E-05 |
| Normal-vs-Stage3 |
1.72000999999478E-05 |
| Normal-vs-Stage4 |
6.170400E-01 |
| Stage1-vs-Stage2 |
7.082600E-01 |
| Stage1-vs-Stage3 |
3.769800E-01 |
| Stage1-vs-Stage4 |
4.391600E-02 |
| Stage2-vs-Stage3 |
2.678400E-01 |
| Stage2-vs-Stage4 |
2.233800E-02 |
| Stage3-vs-Stage4 |
5.666100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.50259837694966E-11 |
| Normal-vs-AfricanAmerican |
1.66610000240652E-08 |
| Normal-vs-Asian |
7.434100E-02 |
| Caucasian-vs-AfricanAmerican |
9.338600E-01 |
| Caucasian-vs-Asian |
9.803600E-01 |
| AfricanAmerican-vs-Asian |
9.995800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.530509218308E-14 |
| Normal-vs-Female |
5.044500E-03 |
| Male-vs-Female |
1.718320E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.605720E-04 |
| Normal-vs-Extreme_Weight |
2.67219579797029E-12 |
| Normal-vs-Obese |
3.24259999961996E-07 |
| Normal-vs-Extreme_Obese |
1.859660E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.537400E-01 |
| Normal_Weight-vs-Obese |
9.018800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.903800E-01 |
| Extreme_Weight-vs-Obese |
9.299600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.467400E-01 |
| Obese-vs-Extreme_Obese |
7.982000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.992200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.81829999962902E-07 |
| Normal-vs-Age(61-80Yrs) |
9.47020240005259E-14 |
| Normal-vs-Age(81-100Yrs) |
5.65909999999947E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.990400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.464600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.802000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.180100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.516000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.888400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.25720545085528E-11 |
| Normal-VS-Type2 PRCC |
6.16679999999592E-05 |
| Normal-VS-KIRP CIMP |
3.566000E-01 |
| Normal-VS-Unclassified PRCC |
1.71353999999235E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.444780E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.065250E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.561200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.728200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.310200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.174440E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.08530000542117E-08 |
| Normal-vs-N1 |
6.334400E-02 |
| Normal-vs-N2 |
7.313800E-01 |
| N0-vs-N1 |
3.281800E-02 |
| N0-vs-N2 |
1.764770E-01 |
| N1-vs-N2 |
7.844600E-01 |
|
|
